Vaginal hyaluronic acid associated with epithelial transformation in symptomatic benign cervical ectopy
This prospective observational study enrolled 121 women diagnosed with symptomatic benign cervical ectopy. The study aimed to assess the specific effects of vaginal hyaluronic acid ovules on epithelial transformation and symptom relief over time.
Participants received vaginal hyaluronic acid ovules (Cicatridine) once daily for 14 days. There was no reported comparator group. The primary outcome showed epithelial transformation rates increased progressively from 61.5% at 4 weeks to 74.6% at 8 weeks and 82.9% at 3 months (p < 0.001). Follow-up assessments occurred at 4 weeks, 8 weeks, and 3 months after treatment. Secondary outcomes included symptom relief, though assessment methods were not standardized.
Safety data regarding adverse events, serious adverse events, discontinuations, and tolerability were not reported in this cohort. Key limitations include the observational design, absence of a control group, and non-standardized symptom assessment. Funding sources and conflicts of interest were not reported.
Clinicians should interpret these findings as exploratory. Further randomized controlled trials are required to determine clinical effectiveness. The association between therapy and transformation should not be overstated regarding symptom relief or clinical effectiveness. Current evidence does not support definitive clinical recommendations.